Filing Details

Accession Number:
0001104659-22-114089
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-02 19:41:03
Reporting Period:
2022-10-31
Accepted Time:
2022-11-02 19:41:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1856725 Rani Therapeutics Holdings Inc. RANI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1854578 Alfonso Isidoro Cortes Quiroga Leonel Aguirre 1830, Apartment 101
Montevideo X3 11500
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-10-31 16,523 $6.11 5,218,821 No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
Class A Common Stock Acquisiton 2022-11-01 3,768 $5.98 5,222,589 No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
Class A Common Stock Acquisiton 2022-11-02 25,197 $6.31 5,247,786 No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
No 4 P Indirect Shares indirectly held through Aequanimitas Limited Partnership
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.96 to $6.22 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.50 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas.